Written question asked by Peter Fortune (Conservative) on Friday, 3 January 2025, in the House of Commons. It was due for an answer on Tuesday, 7 January 2025. It was answered by Justin Madders (Labour) on Friday, 10 January 2025 on behalf of the Department for Business and Trade.
CSL Vifor
- Question
-
To ask the Secretary of State for Business and Trade, if he will make an assessment of the adequacy of the accessibility of the consultation entitled Investigation into suspected anti-competitive conduct by Vifor Pharma in relation to intravenous iron treatments, published on 31 January 2024.
- Answer
-
The Competition and Markets Authority (CMA) is the UK's independent competition authority, and its consultations, including the live consultation relating to commitments offered by Vifor Pharma (https://www.gov.uk/government/consultations/consultation-on-proposed-commitments-in-respect-of-vifor-pharmas-supply-of-intravenous-iron), are therefore independent of Government. Any questions relating to consultations carried out by the CMA should be sent directly to the CMA.
Secondary information
- Type
- Written question
- Reference
- 21836
- Session
- 2024-26
- Subjects
- Competition Medical treatments Anaemia CSL Vifor
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2025-09-05 19:38:48 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-25/21836
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-25/21836
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-25/21836